MTOR and neoplasm: As a dual inhibitor targeting both PI3K and mTOR, VS-5584 (SB2343) efficiently decreased the number of tumor spheres and induced apoptosis of CSCs when co-treated with paclitaxel (PTX), which regulates the cell cycle to stay at G2, inhibiting the cell division [166, 167].